SEC Form 4 · accession 0001567619-18-005303
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline Studer
Officer — CVP, Gen. Counsel & Secretary
Period of report
Nov 6, 2018
Accepted (ET)
Nov 7, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Nov 6, 2018 | S | 3,313 | $201.2746 | D | 4,951 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes Includes 25 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 28, 2018.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $201.04 to a high of $201.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.